HLS Therapeutics Inc at Bloom Burton & Co. Healthcare Investor Conference Transcript
Okay. Our next company this morning is HLS Therapeutics. And we have the CEO, Gilbert Godin, to present the story. Thank you.
Good morning, everyone. Thank you, Michael. Thank you to Brian, Jolyon, and the team at Bloom Burton for getting us all together again. We are very happy to take part in the annual conference. And welcome to all of you in attendance today.
Over the next 15 minutes or so, I will provide general overview of HLS before proceeding with questions. Might break here and there also for questions after certain themes.
HLS is an operating commercial-stage profitable pharma company. We were profitable from day 1 when we launched our company. We are operating in the US and in Canada. We focus on cardiovascular diseases, CNS specialties. And within those segments, we treat chronic conditions with essential medications, which brings stability and resilience to our revenue.
In six years, since we launched HLS, we built a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
